Lataa...
Current and Investigational Therapeutics for Fabry Disease
Fabry disease (FD) is an X-linked lysosomal storage disease caused by a deficiency in the lysosomal enzyme α-galactosidase (α-GAL). This in turn leads to the buildup of globotriaosylceramide, resulting classically in progressive kidney disease, peripheral neuropathy, early-onset cerebrovascular dise...
Tallennettuna:
| Julkaisussa: | Kidney Int Rep |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Elsevier
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7136345/ https://ncbi.nlm.nih.gov/pubmed/32274449 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ekir.2019.11.013 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|